Novartis

Tracked participation in 1 Atlas company, with 0 explicitly attributed leads.

1portfolio companies

1round participations

0lead positions

Dec 2025latest activity

Capital activity

Portfolio

CompanyLatest valuationFirst → latestRoundsRoleAttributed partner

RTRelation TherapeuticsScienceRelation Therapeutics is an AI-driven biopharmaceutical company building a biology-first, lab-and-computation “loop”…$116MraisedRecent roundsSeed (additional investment) · Dec 2025$26M · Data Collective Venture Capital (DCVC), DCVC +2Strategic collaboration (includes equity investment) · Dec 2025$55M · NovartisSeed (new seed financing) · Mar 2024$35M · led by Data Collective Venture Capital (DCVC)Relation Therapeutics—Dec 2025 → Dec 20251 roundParticipant—

DateCompanyRoundRaisedValuationRoleEvidence

Dec 09, 2025RTRelation TherapeuticsScienceRelation Therapeutics is an AI-driven biopharmaceutical company building a biology-first, lab-and-computation “loop”…$116MraisedRecent roundsSeed (additional investment) · Dec 2025$26M · Data Collective Venture Capital (DCVC), DCVC +2Strategic collaboration (includes equity investment) · Dec 2025$55M · NovartisSeed (new seed financing) · Mar 2024$35M · led by Data Collective Venture Capital (DCVC)Relation TherapeuticsStrategic collaboration (includes equity investment)$55M—Participant

Source ↗

DateCompanyRoundRaisedValuationRoleEvidence

Source ↗